Research Article
No access
Published Online: 5 January 2008

Serum TSH and Total T4 in the United States Population and Their Association With Participant Characteristics: National Health and Nutrition Examination Survey (NHANES 1999–2002)

Publication: Thyroid
Volume 17, Issue Number 12

Abstract

Objective: Describe thyrotropin (TSH) and thyroxine (T4) levels in the U.S. population and their association with selected participant characteristics. Design: Secondary analysis of data from the National Health and Nutrition Examination Survey (NHANES) collected from 4392 participants, reflecting 222 million individuals, during 1999–2002. Results: Hypothyroidism prevalence (TSH > 4.5 mIU/L) in the general population was 3.7%, and hyperthyroidism prevalence (TSH < 0.1 mIU/L) was 0.5%. Among women of reproductive age (12–49 years), hypothyroidism prevalence was 3.1%. Individuals aged 80 years and older had five times greater odds for hypothyroidism compared to 12- to 49-year-olds (adjusted odds ratio [OR] = 5.0, p = 0.0002). ORs were adjusted for sex, race, annual income, pregnancy status, and usage of thyroid-related medications (levothyroxine/thyroid, estrogen, androgen, lithium, and amiodarone). Compared to non-Hispanic whites, non-Hispanic blacks had a lower risk for hypothyroidism (OR = 0.46, p = 0.04) and a higher risk for hyperthyroidism (OR = 3.18, p = 0.0005), while Mexican Americans had the same risk as non-Hispanic whites for hypothyroidism, but a higher risk for hyperthyroidism (OR = 1.98, p = 0.04). Among those taking levothyroxine or desiccated thyroid, the adjusted risk for either hypothyroidism (OR = 4.0, p = 0.0001) or hyperthyroidism (OR = 11.4, p = 4 × 10−9) was elevated. Conclusions: Associations with known factors such as age, race, and sex were confirmed using this data set. Understanding the prevalence of abnormal thyroid tests among reproductive-aged women informs decisions about screening in this population. The finding that individuals on thyroid hormone replacement medication often remain hypothyroid or become hyperthyroid underscores the importance of monitoring.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

cover image Thyroid®
Thyroid
Volume 17Issue Number 12December 2007
Pages: 1211 - 1223
PubMed: 18177256

History

Published online: 5 January 2008
Published in print: December 2007

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Yutaka Aoki
Association of Schools of Public Health, Washington, D.C. Current affiliation: Morgan State University, Baltimore, Maryland.
Ruth M. Belin
Eli Lilly and Company, Indianapolis, Indiana.
Robert Clickner
WESTAT, Rockville, Maryland.
Rebecca Jeffries
WESTAT, Rockville, Maryland.
Linda Phillips
U.S. Environmental Protection Agency, Washington, D.C.
Kathryn R. Mahaffey
U.S. Environmental Protection Agency, Washington, D.C.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top